compound 9f

Compound 9f is a synthetic small molecule belonging to a library of 1,2,3-triazole-incorporated 1,3,4-oxadiazole-triazine derivatives. Developed for its potential antineoplastic properties, it was designed as a hybrid molecule combining multiple heterocyclic pharmacophores to enhance biological activity. In vitro evaluations have demonstrated that compound 9f, along with other members of its series (9a-j), possesses significant anticancer activity against various human cancer cell lines, including prostate cancer (PC3 and DU-145), lung cancer (A549), and breast cancer (MCF-7). Molecular docking studies associated with this chemical series typically investigate its binding affinity toward the Epidermal Growth Factor Receptor (EGFR), suggesting its potential role as a targeted kinase inhibitor.